Study immune responses after an flu shot in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study gives you a flu vaccine and measures how your immune system reacts, including both “blood immunity” and “cell immunity.” It’s for healthy adults and mainly aims to better understand how well flu vaccines work in people without major health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and willing to sign a consent form
- Agree to attend all study visits and follow study instructions
- No known allergic reaction to ingredients in the flu vaccine used in the study
- No latex allergy
- No serious past reaction after flu vaccines, and no “GBS” in the last 6 weeks after a flu shot
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people's immune systems respond to the flu. If you have a positive flu test at a Penn Medicine location and are 18 or older, you may be able to join.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This study looks at how your immune system (your body’s infection-fighting system) responds after you get the seasonal flu vaccine. It may help researchers understand what the vaccine triggers in people working in healthcare and labs.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This study tests a flu vaccine given just under the skin (intradermal) to see how well it works. It may be a good option if you are a healthy young adult.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
Hear when a new Influenza, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.